PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
10-Sep-2020 Orgenesis CEO to Participate in Webinar Panel on “New Approaches to COVID-19” on Thursday, September 10th Orgenesis
10-Sep-2020 Kallik joins life sciences organisation Medilink West Midlands as newest patron to help drive growth and collaboration in post-COVID times Kallik
10-Sep-2020 AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020 AstraZeneca
08-Sep-2020 PTC Therapeutics’ 2020 STRIVE Awards for Duchenne Muscular Dystrophy Recognize Four Patient Advocacy Organizations PTC Therapeutics, Inc.
07-Sep-2020 PAGE & PAGE AND PARTNERS ANNOUNCES: NEW PARTNERS, NEW LONDON OFFICE, CLIENTS WINS AND RECRUITMENT DRIVE DURING PANDEMIC Page & Page and Partners
07-Sep-2020 Coulter Partners secures Chief Financial Officer for Saniona Coulter Partners
07-Sep-2020 AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Asklepios BioPharmaceutical, Inc.
07-Sep-2020 Miele offers savings across lab washer range Miele
07-Sep-2020 SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS SPRAVATO®▼ (ESKETAMINE) NASAL SPRAY FOR USE IN TREATMENT OF ADULTS WITH TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER IN SCOTLAND Janssen
03-Sep-2020 World’s Largest Virtual Pharma Expo Agenda Unveiled: Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma CPhI
03-Sep-2020 Janssen responds to NICE draft guidance not to recommend SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder Janssen
03-Sep-2020 Janssen responds to NICE draft guidance not to recommend SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder Janssen
02-Sep-2020 Senior team at healthcare agency Page & Page become Partners Page & Page & Partners
01-Sep-2020 Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. Sanofi
01-Sep-2020 Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies The Institute of Cancer Research
01-Sep-2020 Empagliflozin (Jardiance®) meets primary endpoint in Phase III heart failure trial with and without diabetes Boehringer Ingelheim and Eli Lilly and Company (Lilly)
01-Sep-2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics SOTIO
01-Sep-2020 Biocartis Expands Collaboration with LifeArc Biocartis Group NV
01-Sep-2020 Emergex Vaccines forms US subsidiary (Emergex USA) by acquisition of laboratories, technology and assets of US-based T cell specialist biotech ImmProNano Emergex Vaccines Holding Limited
01-Sep-2020 BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development BioVersys